Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Applied Therapeutics (APLT) Change in Cash (2023 - 2025)

Historic Change in Cash for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to -$18.5 million.

  • Applied Therapeutics' Change in Cash rose 2080.58% to -$18.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.9 million, marking a year-over-year decrease of 24154.37%. This contributed to the annual value of $29.5 million for FY2024, which is 1125.42% down from last year.
  • Per Applied Therapeutics' latest filing, its Change in Cash stood at -$18.5 million for Q3 2025, which was up 2080.58% from -$20.3 million recorded in Q2 2025.
  • Over the past 5 years, Applied Therapeutics' Change in Cash peaked at $96.6 million during Q1 2024, and registered a low of -$28.6 million during Q1 2025.
  • For the 3-year period, Applied Therapeutics' Change in Cash averaged around -$428363.6, with its median value being -$18.5 million (2025).
  • Data for Applied Therapeutics' Change in Cash shows a peak YoY increase of 144290.73% (in 2024) and a maximum YoY decrease of 136724.61% (in 2024) over the last 5 years.
  • Over the past 3 years, Applied Therapeutics' Change in Cash (Quarter) stood at $12.4 million in 2023, then crashed by 256.49% to -$19.5 million in 2024, then grew by 5.1% to -$18.5 million in 2025.
  • Its last three reported values are -$18.5 million in Q3 2025, -$20.3 million for Q2 2025, and -$28.6 million during Q1 2025.